| Clevidipine |
Emulsion |
|
|
Develop a dissolution method |
|
|
2025/09/08 |
| Clindamycin HCl |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Clindamycin Phosphate |
Suppository |
|
|
Develop a method to characterize in vitro release |
|
|
2026/03/25 |
| Clobazam |
Film |
V (Paddle over Disk), with 56 mm, 40 mesh stainless steel disk. |
75 |
0.1 N HCl |
900 |
2, 5, 10, 15, 20 and 30 |
2021/04/22 |
| Clobazam |
Tablet |
II (Paddle) |
75 |
0.1 N HCl (degassed) |
900 |
5, 10, 20, 30, 45 and 60 |
2013/07/31 |
| Clobazam |
Oral Suspension |
II (Paddle) |
75 |
0.1 N HCl (degassed) |
900 |
5, 10, 15, 20, 25 and 30 |
2013/07/31 |
| Clomiphene Citrate |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Clomipramine HCl |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Clonazepam |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Clonazepam |
Suspension |
|
|
Develop a dissolution method |
|
|
2024/11/01 |
| Clonazepam |
Tablet (Orally Disintegrating) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Clonidine |
Transdermal |
|
|
Refer to USP |
|
|
2009/02/18 |
| Clonidine ( 0.1 mg) |
Tablet (Extended Release) |
II (Paddle) with sinker |
50 |
Acid stage: 0.01 N HCl; Buffer stage: Phosphate Buffer, pH 7.0 |
Acid stage: 500; Buffer stage: 500 |
Acid stage: 1 and 2 hours; Buffer stage: 1, 2, 4, 6, 10, 14 and 16 hours |
2012/01/26 |
| Clonidine ( EQ. 0.17 mg and EQ. 0.26 mg) |
Tablet (Extended Release) |
II (Paddle) |
50 |
500 mL 0.1N HCl for the 1st hour, then add 400 mL 0.27M Sodium Phosphate (Dibasic) buffer solution |
Acid stage: 500; Buffer stage: 900 |
1, 2, 3, 6, 9, 12, 16, 20 and 24 hours |
2010/07/01 |
| Clonidine HCl |
Tablet |
|
|
Refer to USP |
|
|
2007/06/18 |
| Clonidine HCl (0.1 mg & 0.2 mg) |
Tablet (Extended Release) |
II (Paddle) with sinker |
50 |
Acid stage: 0.01 N HCl; Buffer stage: Phosphate Buffer, pH 7.0 |
Acid stage: 500; Buffer stage: 500 |
Acid stage: 1 and 2 hours; Buffer stage: 1, 2, 4, 6, 10, 14 and 16 hours |
2015/08/27 |
| Clonidine Hydrochloride |
Suspension, Extended Release |
II (Paddle) |
50 |
0.6 M KH2PO4 solution, pH 4.3 |
900 |
0.5, 1, 2, 3, 4, 6, 8, 12, 14, 16, 18 and 24 hours |
2025/06/23 |
| Clopidogrel Bisulfate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Clorazepate Dipotassium |
Tablet |
|
|
Refer to USP |
|
|
2013/01/31 |
| Clotrimazole |
Tablet (Vaginal) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
10, 20, 30 and 45 |
2004/01/24 |